Preferred Label : Dexamethasone/Liposomal Doxorubicin/Etoposide/Rituximab/Temozolomide Regimen;
NCIt synonyms : TEDD Plus Rituximab; Dexamethasone/Liposomal Doxorubicin/Etoposide/Rituximab/Temozolomide; Temozolomide/Etoposide/Doxil/Dexamethasone/Rituximab; Temozolomide/Etoposide/Doxil/Dexamethasone/Rituximab Regimen; TEDD-R Regimen; Temozolomide/Etoposide/Doxil/Dexamethasone and Rituximab; TEDD-R;
NCIt definition : A regimen consisting of dexamethasone, pegylated liposomal doxorubicin, etoposide,
rituximab and temozolomide that may be used in the treatment of central nervous system
(CNS) lymphoma.;
NCI Metathesaurus CUI : CL1663298;
Origin ID : C180731;
UMLS CUI : C5556596;
Semantic type(s)
chemotherapy_regimen_has_component
concept_is_in_subset